Stage of disease ( p = 0.003 ) , treatment regimen ( p = 0.023 ) , response to chemotherapy ( p = 0.007 ) and SMCA change ( p = 0.040 ) , but not sarcopenia at baseline , were significant prognostic factors in the multivariate survival analyses .